Tocotrienols reverse IKAP and monoamine oxidase deficiencies in familial dysautonomia

Biochemical and Biophysical Research Communications

Volumn 336, Issue 1, 2005, Pages 150-156

  Anderson, Sylvia L ^a   Rubin, Berish Y ^a  

^a FORDHAM UNIVERSITY   (United States)

Author keywords

EGCG; Familial dysautonomia; IKAP; MAO A; Tocotrienol

Indexed keywords

ALPHA TOCOTRIENOL; AMINE OXIDASE (FLAVIN CONTAINING); AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; DOPAMINE; IKAP PROTEIN; ISOENZYME; MESSENGER RNA; NORADRENALIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL; CONTROLLED STUDY; DIAPHORESIS; DOPAMINE BLOOD LEVEL; DYSAUTONOMIA; FETUS; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPERTENSION; MUTATION; NORADRENALIN BLOOD LEVEL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REDUCTION; TACHYCARDIA; VOMITING;

BASE SEQUENCE; CARRIER PROTEINS; DNA PRIMERS; DYSAUTONOMIA, FAMILIAL; HUMANS; MONOAMINE OXIDASE; RNA, MESSENGER; TOCOTRIENOLS;

EID: 24344501293     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.08.054     Document Type: Article

References (57)

1. F.B. Axelrod, R. Nachtigal, and J. Dancis Familial dysautonomia: diagnosis, pathogenesis and management Adv. Pediatr. 21 1974 75 96
2. P.W. Brunt, and V.A. McKusick Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature Medicine (Baltimore) 49 1970 343 374
3. F.B. Axelrod Familial dysautonomia Muscle Nerve 29 2004 352 363
4. S.L. Anderson, R. Coli, I.W. Daly, E.A. Kichula, M.J. Rork, S.A. Volpi, J. Ekstein, and B.Y. Rubin Familial dysautonomia is caused by mutations of the IKAP gene Am. J. Hum. Genet. 68 2001 753 758
5. S.A. Slaugenhaupt, A. Blumenfeld, S.P. Gill, M. Leyne, J. Mull, M.P. Cuajungco, C.B. Liebert, B. Chadwick, M. Idelson, L. Reznik, C. Robbins, I. Makalowska, M. Brownstein, D. Krappmann, C. Scheidereit, C. Maayan, F.B. Axelrod, and J.F. Gusella Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia Am. J. Hum. Genet. 68 2001 598 605
6. S.L. Anderson, J. Qiu, and B.Y. Rubin Tocotrienols induce IKBKAP expression: a possible therapy for familial dysautonomia Biochem. Biophys. Res. Commun. 306 2003 303 309
7. M.P. Cuajungco, M. Leyne, J. Mull, S.P. Gill, W. Lu, D. Zagzag, F.B. Axelrod, C. Maayan, J.F. Gusella, and S.A. Slaugenhaupt Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia Am. J. Hum. Genet. 72 2003 749 758
8. S.L. Anderson, J. Qiu, and B.Y. Rubin EGCG corrects aberrant splicing of IKAP mRNA in cells from patients with familial dysautonomia Biochem. Biophys. Res. Commun. 310 2003 627 633
9. S.A. Slaugenhaupt, J. Mull, M. Leyne, M.P. Cuajungco, S.P. Gill, M.M. Hims, F. Quintero, F.B. Axelrod, and J.F. Gusella Rescue of a human mRNA splicing defect by the plant cytokinin kinetin Hum. Mol. Genet. 13 2004 429 436
10. J.P. Johnston Some observations upon a new inhibitor of monoamine oxidase in brain tissue Biochem. Pharmacol. 17 1968 1285 1297
11. J. Knoll, and K. Magyar Some puzzling pharmacological effects of monoamine oxidase inhibitors Adv. Biochem. Psychopharmacol. 5 1972 393 408
12. C.L. Ravaris, D.S. Robinson, J.O. Ives, A. Nies, and D. Bartlett Use of MAOI antidepressants Fam. Physician 18 1978 105 111
13. G.D. Tollefson Monoamine oxidase inhibitors: a review J. Clin. Psychiatry 44 1983 280 288
14. B. Blackwell Hypertensive crisis due to monoamine-oxidase inhibitors Lancet 38 1963 849 850
15. B. Blackwell, E. Marley, and A. Ryle Hypertensive crisis associated with monoamine-oxidase inhibitors Lancet 15 1964 722 723
16. D. Horwitz, W. Lovenberg, K. Engelman, and A. Sjoerdsma Monoamine oxidase inhibitors, tyramine and cheese JAMA 188 1964 1108 1110
17. J.I. Walker, J. Davidson, and W.W. Zung Patient compliance with MAO inhibitor therapy J. Clin. Psychiatry 45 1984 78 80
18. S.B. Lippman, and K. Nash Monoamine oxidase inhibitor update. Potential adverse food and drug interactions Drug Saf. 5 1990 195 204
19. M.C. Anderson, F. Hasan, J.M. McCrodden, and K.F. Tipton Monoamine oxidase inhibitors and the cheese effect Neurochem. Res. 18 1993 145 149
20. K.F. Ilett, C.F. George, and D.S. Davies The effect of monoamine oxidase inhibitors on 'first-pass' metabolism of tyramine in dog intestine Biochem. Pharmacol. 29 1980 2551 2556
21. B. McCabe, and M.T. Tsuang Dietary consideration in MAO inhibitor regimens J. Clin. Psychiatry 43 1982 178 181
22. F. Hasan, J.M. McCrodden, N.P. Kennedy, and K.F. Tipton The involvement of intestinal monoamine oxidase in the transport and metabolism of tyramine J. Neural Transm. Suppl. 26 1988 1 9
23. S.E. Mayer A.G. Gilman L.S. Goodman A. Gilman The Pharmacological Basis of Therapeutics sixth ed. 1980 The Macmillan Company New York 82 Chapter 4
24. M.B. Youdim, E. Heldman, H.B. Pollard, P. Fleming, and E. McHugh Contrasting monoamine oxidase activity and tyramine induced catecholamine release in PC12 and chromaffin cells Neuroscience 19 1986 1311 1318
25. A.A. Smith, and J. Dancis Exaggerated response to infused norepinephrine in familial dysautonomia N. Engl. J. Med. 270 1964 704 707
26. J. Dancis Altered drug response in familial dysautonomia Ann. NY Acad. Sci. 151 1968 876 879
27. P. Chaitidis, E.E. Billett, V.B. O'Donnell, A.B. Fajardo, J. Fitzgerald, R.J. Kuban, U. Ungethuem, and H. Kuhn Th2 response of human peripheral monocytes involves isoform-specific induction of monoamine oxidase-A J. Immunol. 173 2004 4821 4827
28. N.A. Hawkes, G. Otero, G.S. Winkler, N. Marshall, M.E. Dahmus, D. Krappmann, C. Scheidereit, C.L. Thomas, G. Schiavo, H. Erdjument-Bromage, P. Tempst, and J.Q. Svejstrup Purification and characterization of the human elongator complex J. Biol. Chem. 277 2002 3047 3052
29. C. Holmberg, S. Katz, M. Lerdrup, T. Herdegen, M. Jaattela, A. Aronheim, and T. Kallunki A novel specific role for I kappa B kinase complex-associated protein in cytosolic stress signaling J. Biol. Chem. 277 2002 31918 31928
30. L.A. Cockhill, and R.A. Remick Blood pressure effects of monoamine oxidase inhibitors-the highs and lows Can. J. Psychiatry 32 1987 803 808
31. R.A. Remick, C. Froese, and F.D. Keller Common side effects associated with monoamine oxidase inhibitors Prog. Neuropsychopharmacol. Biol. Psychiatry 13 1989 497 504
32. F.B. Axelrod, D.S. Goldstein, C. Holmes, D. Berlin, and I.J. Kopin Pattern of plasma levels of catecholamines in familial dysautonomia Clin. Auton. Res. 6 1996 205 209
33. J. Pearson, F. Axelrod, and J. Dancis Current concepts of dysautonomia: neuropathological defects Ann. NY Acad. Sci. 228 1974 288 300
34. J. Pearson, B.A. Pytel, N. Grover-Johnson, F. Axelrod, and J. Dancis Quantitative studies of dorsal root ganglia and neuropathologic observations on spinal cords in familial dysautonomia J. Neurol. Sci. 35 1978 77 92
35. K.N. Westlund, R.M. Denney, L.M. Kochersperger, R.M. Rose, and C.W. Abell Distinct monoamine oxidase A and B populations in primate brain Science 230 1985 181 183
36. K.N. Westlund, R.M. Denney, R.M. Rose, and C.W. Abell Localization of distinct monoamine oxidase A and monoamine oxidase B cell populations in human brainstem Neuroscience 25 1988 439 456
37. K.L. Double, and A.D. Crocker Dopamine receptors in the substantia nigra are involved in the regulation of muscle tone Proc. Natl. Acad. Sci. USA 92 1995 1669 1673
38. K. Takakusaki, T. Habaguchi, J. Ohtinata-Sugimoto, K. Saitoh, and T. Sakamoto Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction Neuroscience 119 2003 293 308
39. F.B. Axelrod Familial dysautonomia D. Robertson P.A. Low R.J. Polinsky Primer on the Autonomic Nervous System 1996 Academic Press San Diego 242 249
40. S. Murase, M. Takayama, and S. Nosaka Chemical stimulation of the nucleus locus coeruleus: cardiovascular responses and baroreflex modification Neurosci. Lett. 153 1993 1 4
41. R.J. Grindstaff, R.R. Grindstaff, M.J. Sullivan, and J.T. Cunningham Role of the locus ceruleus in baroreceptor regulation of supraoptic vasopressin neurons in the rat Am. J. Physiol. Regul. Integr. Comp. Physiol. 279 2000 R306 R319
42. M. Elam, T. Yao, P. Thoren, and T.H. Svensson Hypercapnia and hypoxia: chemoreceptor-mediated control of locus coeruleus neurons and splanchnic, sympathetic nerves Brain Res. 222 1981 373 381
43. K. Nieber, J. Sevcik, and P. Illes Hypoxic changes in rat locus coeruleus neurons in vitro J. Physiol. 486 1995 33 46
44. C. Maayan, F.B. Axelrod, S. Akselrod, D.W. Carley, and D.C. Shannon Evaluation of autonomic dysfunction in familial dysautonomia by power spectral analysis J. Auton. Nerv. Syst. 21 1987 51 58
45. F.B. Axelrod, D. Putman, D. Berlin, and M. Rutkowski Electrocardiographic measures and heart rate variability in patients with familial dysautonomia Cardiology 88 1997 133 140
46. B. Stemper, L. Bernardi, F.B. Axelrod, G. Welsch, C. Passino, and M.J. Hilz Sympathetic and parasympathetic baroreflex dysfunction in familial dysautonomia Neurology 63 2004 1427 1431
47. L. Bernardi, M. Hilz, B. Stemper, C. Passino, G. Welsch, and F.B. Axelrod Respiratory and cerebrovascular responses to hypoxia and hypercapnia in familial dysautonomia Am. J. Respir. Crit. Care Med. 167 2003 141 149
48. M. Tsuruoka, K. Matsutani, M. Maeda, and T. Inoue Coeruleotrigeminal inhibition of nociceptive processing in the rat trigeminal subnucleus caudalis Brain Res. 993 2003 146 153
49. H. Monnikes, B.G. Schmidt, J. Tebbe, C. Bauer, and Y. Tache Microinfusion of corticotropin releasing factor into the locus coeruleus/subcoeruleus nuclei stimulates colonic motor function in rats Brain Res. 644 1994 101 108
50. L. Marson Identification of central nervous system neurons that innervate the bladder body, bladder base, or external urethral sphincter of female rats: a transneuronal tracing study using pseudorabies virus J. Comp. Neurol. 389 1997 584 602
51. J. Saini, F.B. Axelrod, C. Maayan, J. Stringer, and S.W. Smilen Urinary incontinence in familial dysautonomia Int. Urogynecol. J. Pelvic Floor Dysfunct. 14 2003 209 213
52. C. Villalobos, L. Nunez, L.S. Frawley, J. Garcia-Sancho, and A. Sanchez Multi-responsiveness of single anterior pituitary cells to hypothalamic- releasing hormones: a cellular basis for paradoxical secretion Proc. Natl. Acad. Sci. USA 94 1997 14132 14137
53. P.M. Rodier, B. Kates, W.A. White, and C.J. Phelps Birthdates of the growth hormone releasing factor cells of the rat hypothalamus: an autoradiographic study of immunocytochemically identified neurons J. Comp. Neurol. 291 1990 63 72
54. M.K. Kamboj, F.B. Axelrod, R. David, M.E. Geffner, M. Novogroder, S.E. Oberfield, J.H. Turco, C. Maayan, and B. Kohn Growth hormone treatment in children with familial dysautonomia J. Pediatr. 144 2004 63 67
55. C.A. Owesson, S.E. Hopwood, L.F. Callado, I. Seif, D.P. McLaughlin, and J.A. Stamford Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice Eur. J. Neurosci. 15 2002 516 522
56. C.A. Owesson, I. Seif, D.P. McLaughlin, and J.A. Stamford Different alpha(2) adrenoceptor subtypes control noradrenaline release and cell firing in the locus coeruleus of wildtype and monoamine oxidase-A knockout mice Eur. J. Neurosci. 18 2003 34 42
57. L. Oreland, and G. Engberg Relation between brain monoamine oxidase (MAO) activity and the firing rate of locus coeruleus neurons Naunyn Schmiedebergs Arch. Pharmacol. 333 1986 235 239